216 related articles for article (PubMed ID: 31035301)
1. Alteration in GPIIb/IIIa Binding of VWD-Associated von Willebrand Factor Variants with C-Terminal Missense Mutations.
König G; Obser T; Marggraf O; Schneppenheim S; Budde U; Schneppenheim R; Brehm MA
Thromb Haemost; 2019 Jul; 119(7):1102-1111. PubMed ID: 31035301
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
3. New assay for measuring binding of platelet glycoprotein IIb/IIIa to unpurified von Willebrand factor.
Veyradier A; Jumilly AL; Ribba AS; Obert B; Houllier A; Meyer D; Girma JP
Thromb Haemost; 1999 Jul; 82(1):134-9. PubMed ID: 10456467
[TBL] [Abstract][Full Text] [Related]
4. On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood.
Endenburg SC; Hantgan RR; Lindeboom-Blokzijl L; Lankhof H; Jerome WG; Lewis JC; Sixma JJ; de Groot PG
Blood; 1995 Dec; 86(11):4158-65. PubMed ID: 7492773
[TBL] [Abstract][Full Text] [Related]
5. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
Naimushin YA; Mazurov AV
Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313
[TBL] [Abstract][Full Text] [Related]
7. Gain-of-Function Variant p.Pro2555Arg of von Willebrand Factor Increases Aggregate Size through Altering Stem Dynamics.
Huck V; Chen PC; Xu ER; Tischer A; Klemm U; Aponte-Santamaría C; Mess C; Obser T; Kutzki F; König G; Denis CV; Gräter F; Wilmanns M; Auton M; Schneider SW; Schneppenheim R; Hennig J; Brehm MA
Thromb Haemost; 2022 Feb; 122(2):226-239. PubMed ID: 33385180
[TBL] [Abstract][Full Text] [Related]
8. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Grainick HR; Williams SB; Coller BS
J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
[TBL] [Abstract][Full Text] [Related]
9. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958
[TBL] [Abstract][Full Text] [Related]
10. Selective inactivation of Von Willebrand factor binding to glycoprotein IIb/IIIa and to inhibitor monoclonal antibody 9 by site-directed mutagenesis.
Jumilly AL; Veyradier A; Ribba AS; Meyer D; Girma JP
Hematol J; 2001; 2(3):180-7. PubMed ID: 11920243
[TBL] [Abstract][Full Text] [Related]
11. Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction.
Wu YP; Vink T; Schiphorst M; van Zanten GH; IJsseldijk MJ; de Groot PG; Sixma JJ
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1661-7. PubMed ID: 10845886
[TBL] [Abstract][Full Text] [Related]
12. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
[TBL] [Abstract][Full Text] [Related]
13. Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54.
Naimushin YA; Mazurov AV
Biochemistry (Mosc); 2005 Jul; 70(7):782-9. PubMed ID: 16097942
[TBL] [Abstract][Full Text] [Related]
14. Shear stress-induced binding of von Willebrand factor to platelets.
Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.
Tischer A; Brehm MA; Machha VR; Moon-Tasson L; Benson LM; Nelton KJ; Leger RR; Obser T; Martinez-Vargas M; Whitten ST; Chen D; Pruthi RK; Bergen HR; Cruz MA; Schneppenheim R; Auton M
J Mol Biol; 2020 Jan; 432(2):305-323. PubMed ID: 31628947
[TBL] [Abstract][Full Text] [Related]
16. Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets.
Kroner PA; Kluessendorf ML; Scott JP; Montgomery RR
Blood; 1992 Apr; 79(8):2048-55. PubMed ID: 1373334
[TBL] [Abstract][Full Text] [Related]
17. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
18. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
Mondoro TH; Wall CD; White MM; Jennings LK
Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
[TBL] [Abstract][Full Text] [Related]
19. A tripeptide mimetic of von Willebrand factor residues 981-983 enhances platelet adhesion to fibrinogen by signaling through integrin alpha(IIb)beta3.
Litjens PE; Van Willigen G; Weeterings C; Ijsseldijk MJ; Van Lier M; Koivunen E; Gahmberg CG; Akkerman JW
J Thromb Haemost; 2005 Jun; 3(6):1274-83. PubMed ID: 15946218
[TBL] [Abstract][Full Text] [Related]
20. [Chronic peripheral arterial occlusive disease, platelet glycoproteins GPIIb-IIIa and GP Ib-IX, plasma von Willebrand factor and plasma fibrinogen concentrations in patients with type 2 diabetes mellitus].
Gosk-Bierska I; Adamiec R; Doskocz W; Ciosek W
Pol Arch Med Wewn; 2000; 103(3-4):139-45. PubMed ID: 11236240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
